TY Howton
Net worth: 771 265 $ as of 2026-05-30
Net worth: 771 265 $ as of 2026-05-30
David Tyronne Howton is Director at Biogene Therapeutics, Inc. since 2026.
Mr. Howton is Chief Operating Officer & Secretary at Solid Biosciences, Inc. since 2023.
Former roles include Director at Make-A-Wish Foundation of Massachusetts, Chief Healthcare Compliance Officer at Genentech, Inc., Secretary, Chief Legal Officer & Senior VP at Vertex Pharmaceuticals, Inc. in 2012, Secretary, Senior Vice President & General Counsel at Sarepta Therapeutics, Inc. from 2013 to 2020, and Chief Operating Officer & General Counsel at AavantiBio, Inc. from 2021 to 2022.
Education includes undergraduate studies at Yale University and graduate studies at Northwestern University School of Law.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-30 | 105,077 ( 0.11% ) | 771 265 $ | 2026-05-30 |
| Companies | Position | Start |
|---|---|---|
| SOLID BIOSCIENCES INC. | Chief Operating Officer | 2023-08-31 |
| Companies | Position | End |
|---|---|---|
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Chief Operating Officer | 2022-11-30 |
| SAREPTA THERAPEUTICS, INC. | General Counsel | - |
| VERTEX PHARMACEUTICALS INCORPORATED | General Counsel | 2012-06-11 |
Make-A-Wish Foundation of Massachusetts | Director/Board Member | - |
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 8 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Vertex Pharmaceuticals, Inc.
Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures micro-dystrophin gene therapy | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Make-A-Wish Foundation of Massachusetts | |
Northwestern University School of Law
Northwestern University School of Law Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Solid Biosciences, Inc.
Solid Biosciences, Inc. BiotechnologyHealth Technology Operates as a pharmaceutical company that develops treatments through gene therapy for patients with duchenne disease | Health Technology |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Health Technology |
Select your edition
All financial news and data tailored to specific country editions